Diyabet tani ve tedavi rehberi 2017-12x21cm indd

KAH: 
Koroner arter hastalığı 
KB: 
Kan basıncı
kcal: 
Kilokalori
KG: 
Kan glukoz 
KH: 
Karbonhidrat
KH/İ: 
Karbonhidrat /insülin oranı 
KKB:
 Kalsiyum kanal blokerleri 
KŞ: 
Kan şekeri
KV: 
Kardiyovasküler
KVH:
 Kardiyovasküler hastalık
LDL-kolesterol:
 Düşük 
yoğunluklu lipoprotein kolesterol
Mİ: 
Miyokard infarktüsü 
MODY1-6:
 Gençlerde görülen 
erişkin tipi diyabet formları 1-6 
(maturity onset diabetes of the 
young 1-6)
MUS: 
Monounsatüre
NeuroD1:
 Nörojenik 
diferansiyasyon 1
OAD: 
Oral antidiyabetik
OGTT:
 Oral glukoz tolerans testi
PG: 
Plazma glukozu
PKOS: 
Polikistik over sendromu
RAS: 
Renin-anjiyotensin sistemi
SC:
 Cilt altı (subcutaneous)
1. st PG:
 1. st plazma glukozu
2. st PG: 
2. st plazma glukozu
3. st PG:
 3. st plazma glukozu
SMBG: 
Evde kan glukoz ölçümü 
(self monitoring of blood glucose)
SKB: 
Sistolik kan basıncı
SSRİ:
 Selektif serotonin gerialım 
inhibitörleri
st:
 saat
SU: 
Sulfonilüre
TBT:
 Tıbbi beslenme tedavisi
TİD:
 Toplam insülin dozu 
(günlük) 
TKG: 
Tokluk kan glukozu
TPPG:
 Tokluk pik prandial 
plazma glukozu
UAE:
 Üriner albümin atılımı
WHO: 
Dünya Sağlık Örgütü 
(World Health Organization)
KISALTMALAR
 
 Ek / 3-2

---

TÜRKDİAB Diyabet Tanı ve Tedavi Rehberi 2017
134

---

135
TÜRKDİAB Diyabet Tanı ve Tedavi Rehberi 2017
KAYNAKÇA
KAYNAKÇA

---

TÜRKDİAB Diyabet Tanı ve Tedavi Rehberi 2017
136
KAYNAKÇA
ACE/AACE Diabetes Road Map Task Force. Road maps to achieve 
glycaemic control in type 2 diabetes mellitus. Endocrine Practice 2007; 
13: 261-9
ADVANCE Collaborative Group: Intensive blood glucose control and 
vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 
358:2560-72
Aiello LP, Cavallerano J, Klein R: Diabetic eye disease. In Endocrinology. 
DeGroot LJ, J Saunders, eds. Philadelphia 2001; 1305-17
American Diabetes Association: Standarts Medical Care in Diabetes 
2015. Diabetes Care 2015;38: S1-S94
American Diabetes Association: Concensus Reports. Diabetes Care 
2013;36 (Suppl 1): S3-S97
American Diabetes Association: Consensus Development Conference on 
Diabetic Foot Wound Care (Consensus Statement). Diabetes Care 1999; 
22:1354–60
American Diabetes Association: Detection and management of lipid 
disorders in diabetes. Diabetes Care 1993; 16: 828–34
American Diabetes Association: Diabetes mellitus and exercise. Diabetes 
Care 2001; 24: S51–5
American Diabetes Association: Diagnosis and classification of diabetes 
mellitus. Diabetes Care 2011; 34 (Suppl. 1): S62-9
American Diabetes Association: Economic consequence of diabetes 
mellitus in the USA in 1997. Diabetes Care 1998; 21: 296–309
American Diabetes Association: Gestational diabetes mellitus. Diabetes 
Care 2003; 26 (Suppl. 1): S103-5
American Diabetes Association: Hypertension management in adults with 
dia- betes. Diabetes Care 2004; 27 (Suppl. 1): S65–7
American Diabetes Association: Management of dyslipidemia in adults 
with diabetes. Diabetes Care 2003; 26(Suppl. 1): S83-6
American Diabetes Association: Nephropathy in diabetes. Diabetes Care 
2004; 27 (Suppl. 1): S79-83
American Diabetes Association: Nutrition recommendations and 
interventions for diabetes. Diabetes Care 2008:31(Suppl 1): S48-65

---

137
TÜRKDİAB Diyabet Tanı ve Tedavi Rehberi 2017
KAYNAKÇA
American Diabetes Association: Peripheral arterial disease in people with 
diabetes. Diabetes Care 2003; 26: 3333-41
American Diabetes Association: Preventive foot care in diabetes. Diabetes 
Care 2004; 27 (Suppl 1): S63-4
American Diabetes Association: Preventive foot care in people with 
diabetes (Po- sition Statement). Diabetes Care 2003; 26 (Suppl.1): S78–9
American Diabetes Association: Standards of medical care in diabetes. 
Diabetes Care 2005; 28 (Suppl. 1): S4 -36
American Diabetes Association: Standards of medical care in 
diabetes-2011. Diabetes Care 2011; 34 ( Suppl. 1): S11-61
American Diabetes Association: Treatment of hypertension in adults with 
diabetes. Diabetes Care 2003; 26 (Suppl. 1): S80-2
American Diabetes Association, European Association for the Study of 
Diabetes, International Federation of Clinical Chemistry and Laboratory 
Medicine, and the International Diabetes Federation Consensus 
Committee: Consensus statement on the world wide standardization of 
the hemoglobin A1C measurement. Diabetes Care 2007; 30: 2399-400
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, 
Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin P-H, Karanja N, 
Simons-Morton D, Mc- Cullough M, Swain J, Steele P, Evans MA, Miller 
ER, Harsha DW, for The DASH Collaborative Research Group: A clinical 
trial of the effects of dietary patterns on blood pressure . N Engl J Med 
1997; 336: 1117-24.
Arauz-Pacheco C, Parrott MA, Raskin P: The treatment of hypertension 
in adult patients with diabetes (Technical Review). Diabetes Care 2002; 
25:134–47
Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, 
Dou- glas J, Hsueh W, Sowers J: Preserving renal function in adults with 
hypertension and diabetes: a consensus approach. Am J Kid Dis 2000; 
36: 646–61
Bansal V, Kalita J, Misra UK: Diabetic neuropathy. Post Graduate Med J 
2006; 82: 95-100
Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: 
epidemiology, pathophysiology, and management. JAMA 2002; 287: 
2570–81

---

TÜRKDİAB Diyabet Tanı ve Tedavi Rehberi 2017
138
Bennett PH, Knowler WC: Definition, Diagnosis, and Classification of 
Diabetes Mellitus and Glucose Homeostasis. In Joslin’s Diabetes Mellitus. 
Kahn CR, Weir CR, King CL, Moses AC, Smith RC, Jacobson AM, eds. 
Lippincott Williams&Wilkins, 2006; 332-9
Berthet K, Neal BC, Chalmers J, Macmahon S, Bousser M, Colman S, 
Woodward M on behalf of the PROGRESS Collaborative Group: Reductions 
in the risks of recurrent stroke in patients with and without diabetes: the 
PROGRESS trial. Blood Pressure 2004; 13: 7–13
Bloomgarden ZT: Diabetic neuropathy. Diabetes Care 2007; 30: 1027-32
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving 
HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, RENAAL Study 
Investigators: Effects of losartan on renal and cardiovascular outcomes 
in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 
345(12): 861-9
Brown SA, Upchurch S, Anding R, Winter M, Ramirez G:Promoting weight 
loss in type II diabetes. Diabetes Care, 1996; 19: 613-24
Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca 
V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, 
Redberg R, Stitzel KF, Stone NJ : Primary prevention of cardiovascular 
diseases in people with diabetes mellitus: a scientific statement from the 
American Heart Association and the American Diabetes Association. 
Diabetes Care 2007; 30: 162– 72
Buse JB. Management of type 2 diabetes mellitus. In Endocrinology. 
DeGroot LJ, J Saunders, eds. Philadelphia 2001; 1231-48
Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, 
Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg 
R, Stitzel KF, Stone NJ: Primary prevention of cardiovascular diseases in 
people with diabetes mellitus: a scientific statement from the American 
Heart Association and the American Diabetes Association. Circulation 2007; 
115(1): 114-26
Cai J, Boulton M: The pathogenesis of diabetic retinopathy: old concept and 
new questions. Eye 2002; 16: 242-60
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee: 
2008 Clinical Practice Guidelines for the Prevention and Management of 
Diabetes in Canada. Can J Diabetes 2008;32 (Suppl.2): S1-S15
Canadian Diabetes Association Clinical Practice Guidlines Expert Committee. 
Reducing the risk of developing diabetes. Can J Diabetes 2013; 37 S16-S19